Infinity Pharmaceuticals, Inc. (INFI)
The Company's mission is to discover, develop, and deliver to patients medicines for the treatment of cancer and related conditions.
Recs
pjani06
(98.13)
Submitted: 7/23/2009 6:56:34 PM :
Start Price:
$8.13
INFI Score:
-39.33
outperform. company is HIGH in cash. not terribly overvalued, and is likely to kill S&P 500 where it is at today's levels.
additionally these companies are not within the financials nor energy sectors.
Recs
djkumquat
(89.90)
Submitted: 4/20/2009 11:53:33 AM :
Start Price:
$5.59
INFI Score:
-23.66
getting near cash value. nearly no debt.
Recs
EMG114
(24.05)
Submitted: 4/23/2008 3:27:37 PM :
Start Price:
$7.04
INFI Score:
+3.61
Good investment for the long-term...
Recs
tharlow
(< 20)
Submitted: 8/24/2007 3:42:26 AM :
Start Price:
$10.16
INFI Score:
-19.43
This will be absolutely massive.
Recs
cardiacarrest
(< 20)
Submitted: 1/12/2007 10:32:50 AM :
Start Price:
$14.10
INFI Score:
-39.43
Yes the madly ambitious Julian Adams at least has a track record to back up his new venture in Infinity. He and his sharp CEO have gone from basically nothing to on the market and in the clinic in 3 years. It should keep charging along....
Recs
spoonbillmgmt
(< 20)
Submitted: 12/3/2006 7:13:05 PM :
Start Price:
$13.64
INFI Score:
-39.05
Enough cash to last until 2009. A promising drug in Phase I trials. Run by a madly ambitious Rhodes Scholar. Technology from some of the world's greatest chemists AND the developer of Velcade. A technique for developing small-molecule drugs with some of the complex folding of actual proteins. A very experienced team, mostly from Millenium. And, if you subtract out the cash they will have on hand early next quarter, you can buy all of this for less than the money already invested by venture capitalists.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 6 of 6